Publications by authors named "Rod Dunbar"

Claim this Profile
E
Efficient Dual Cas9 Nickase Correction of a Prevalent Pathogenic Variant for Junctional Epidermolysis Bullosa.
Alex du Rand, John Hunt, Daniel Verdon, Ben Buttle, P Rod Dunbar

JID Innov· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to digital characterisation of Tertiary Lymphoid Structures in colorectal cancer.
Luis Munoz-Erazo, Saem Mul Park, Shelly Lin, Chun-Jen J Chen, Lisa Y Y Zhou, P Rod Dunbar

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human keratinocytes grown at a gas-permeable interface in vitro stratify correctly to generate engineered human epidermis.
Vaughan Feisst, Lisa Y Y Zhou, Chun-Jen Jennifer Chen, Eloise Williams, Elliott Dunn, P Rod Dunbar

Cytotherapy· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced HDR-mediated correction of heterozygous mutations for recessive dystrophic epidermolysis bullosa.
John M T Hunt, Alex du Rand, Daniel Verdon, Leah Clemance, Evert Loef, P Rod Dunbar

Mol Ther Nucleic Acids· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics.
Laurent Renesme, Kelly D Cobey, Manoj M Lalu, Tania Bubela, Raghavan Chinnadurai, Rod Dunbar

Cytotherapy· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa.
Alex du Rand, John Hunt, Christopher Samson, Evert Loef, Chloe Malhi, Rod Dunbar

Bioeng Transl Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors.
Saem Mul Park, Chun-Jen J Chen, Daniel J Verdon, Marcus P Y Ooi, Anna E S Brooks, P Rod Dunbar

Front Immunol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral PD-L1 inhibitor GS-4224 selectively engages PD-L1 high cells and elicits pharmacodynamic responses in patients with advanced solid tumors.
Jared M Odegard, Ahmed A Othman, Kai-Wen Lin, Adele Y Wang, Jonathan Nazareno, P Rod Dunbar

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection.
Harry L Janssen, Young-Suk Lim, Hyung Joon Kim, Leonard Sowah, Cheng-Hao Tseng, P Rod Dunbar

JHEP Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma.
Nathaniel Dasyam, Katrina J Sharples, Catherine Barrow, Ying Huang, Evelyn Bauer, P Rod Dunbar

Cancer Immunol Immunother· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections.
Saem Mul Park, Chun-Jen J Chen, Joanna E Mathy, Shelly C Y Lin, Richard C W Martin, P Rod Dunbar

J Immunol Methods· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression.
Edward J Gane, P Rod Dunbar, Anna E Brooks, Fangqiu Zhang, Diana Chen

J Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid culture of human keratinocytes in an autologous, feeder-free system with a novel growth medium.
Vaughan Feisst, Inken Kelch, Elliott Dunn, Eloise Williams, Sarah Meidinger, P Rod Dunbar

Cytotherapy· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasminogen and plasmin can bind to human T cells and generate truncated CCL21 that increases dendritic cell chemotactic responses.
Evert J Loef, Hilary M Sheppard, Nigel P Birch, P Rod Dunbar

J Biol Chem· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-Cell Microscopy Reveals That Human T Cells Primarily Respond Chemokinetically Within a CCL19 Gradient That Induces Chemotaxis in Dendritic Cells.
Evert J Loef, Hilary M Sheppard, Nigel P Birch, P Rod Dunbar

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migratory cues controlling B-lymphocyte trafficking in human lymph nodes.
Saem Mul Park, Anna Es Brooks, Chun-Jen J Chen, Hilary M Sheppard, Evert Jan Loef, P Rod Dunbar

Immunol Cell Biol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinctive Subpopulations of Stromal Cells Are Present in Human Lymph Nodes Infiltrated with Melanoma.
Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J Chen, Joanna E Mathy, P Rod Dunbar

Cancer Immunol Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma.
Jonathan S Cebon, Martin Gore, John F Thompson, Ian D Davis, Grant A McArthur, P Rod Dunbar

J Immunother Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines.
Benjamin L Lu, Geoffrey M Williams, Daniel J Verdon, P Rod Dunbar, Margaret A Brimble

J Med Chem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR Analysis of Lipovelutibols B and D and Their Lipid Analogues.
Alan J Cameron, Emma K Davison, Chalice An, Louise A Stubbing, P Rod Dunbar

J Org Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Are a Heterogeneous Population That Demonstrate Rapid Culture-Induced Changes.
Anna E S Brooks, Megan Iminitoff, Eloise Williams, Tanvi Damani, Victoria Jackson-Patel, P Rod Dunbar

Front Pharmacol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroserpin regulates human T cell-T cell interactions and proliferation through inhibition of tissue plasminogen activator.
Evert Jan Loef, Anna E S Brooks, Natalie Lorenz, Nigel P Birch, P Rod Dunbar

J Leukoc Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution 3D imaging and topological mapping of the lymph node conduit system.
Inken D Kelch, Gib Bogle, Gregory B Sands, Anthony R J Phillips, Ian J LeGrice, P Rod Dunbar

PLoS Biol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study.
Edward Gane, Daniel J Verdon, Anna E Brooks, Anuj Gaggar, Anh Hoa Nguyen, P Rod Dunbar

J Hepatol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases.
Christian Schwabe, Bernd Rosenstock, Thi Doan, Paul Hamilton, P Rod Dunbar

J Clin Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis